8-Bromo-6-(trifluoromethyl)-[1,2,4]triazolo[1,5-a]pyridine, 95+%, 1g

2-(4-Phenylpiperazin-1-yl)acetic acid, 98%, 1g

7-chloro-1H-[1,2,3]triazolo[4,5-b]pyridine, 97%, 10g

Di-tert-butyl 5-methyl-2,4-dioxopyrimidine-1,3(2H,4H)-dicarboxylate, 97.0%, 10g

5-Hydroxyoctan-4-one, 95.0%, 25g

2,6-Dimethylbenzoic acid, 98.0%, 1g

2-chloro-N,N-dimethylisonicotinamide, 95.0%, 250mg

4-Amino-6-methylpyridine-3-carbonitrile, 98%, 100mg

(8aR)-8a-methyl-octahydropyrrolo[1,2-a]pyrazine dihydrochloride, 250mg

5-(4-Bromophenyl)pyrrolidin-2-one, 95.0%, 250mg

Stéarate de magnésium, min 95%, pour la biochimie, 100 g, emballage plastique.

N-(3-bromobenzyl)-N-(tert-butyl)amine, 97%, 1g

Methyl 4-bromopyrimidine-2-carboxylate, 97%, 1g